1 / 3

Nice Guidelines Heavy Menstrual Bleeding : Assessment and management

Summary of NICE guidance on heavy menstrual bleeding -assessment and management 2018<br>Evaluate impact-u00a0Heavy menstrual bleeding ( HMB ) is one of the commonest reason for gynecological referral and consultations About 1 in 20 women aged 30-49 yrs see GP/ year for HMB or menstrual problems Menstrualu00a0<br>https://www.a4medicine.co.uk/heavy-menstrual-bleeding/<br>

Download Presentation

Nice Guidelines Heavy Menstrual Bleeding : Assessment and management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Heavy menstrual bleeding-NICE Heavy Menstrual Bleeding- assessment and management Evaluate impact- Heavy menstrual bleeding ( HMB ) is one of the commonest reason for gynecological referral and consultations About 1 in 20 women aged 30-49 yrs see GP/ year for HMB or menstrual problems Menstrual disorders comprise 
 12 % of all referral to gynecology service The guideline states that HMB has a major impact on a womens QOL and advises to ensure that any intervention should aim to improve this rather than focusing on blood loss HMB -a report has shown- 74 % suffered anxiety 67 % depression 62 % reported impact on physical wellbeing history Examination and Testing – Nature of bleeding Related symptoms as
 ○ persistent IMB
 ○ pelvic pain and / or pressure symptoms
 -may indicate uterine cavity abnormality 
 - histological abnormality
 -

  2. adenomyosis or fibroids Impact on QOL Co-morbidities Previous treatment of HMB Take into account the range & natural variability in menstrual cycles and blood loss when diagnosing HMB -discuss the variation. Discuss care options if the women feels she does not fall within the normal range. Physical examination HMB without other related symptoms – Consider pharmacological management without carrying out a physical examination. Undertake a physical examination-HMB with other related symptoms Before all investigations or LNG-IUS fittings Lab tests – FBC – for all with HMB in parallel with any HMB treatment offered
 Coagulation disorders eg von Willerbrand’s disease if
 ○ have had HMB since their periods started and
 ○ have a personal or family hx suggestive of a coagulation disorder
 TFT not routinely indicated unless other signs and symptoms of thyroid illness investigating the cause –History and or examination suggests a low risk of fibroids uterine cavity abnormality histological abnormality or adenomyosis. Consider starting pharmacological
 management without investigating the cause. Cancer suspected- USC. Take into account history and examination to decide which first line to offer. Outpatient hysteroscopy. If hx suggests
 ○ submucosal fibroids
 ○ polyps or
 ○ endometrial pathology
 
 because they have
 
 ○ symptoms as persistent intermenstrual bleeding
 
 ○ risk factors for endometrial pathology. NICE clarifies further that these are women with
 
 - persistent intermenstrual or persistent irregular bleeding who are obese or have PCOS
 - women who are on tamoxifen
 - women for whom treatment for HMB has been unsuccessful
 NICE has set-out guidance for organization and standards for the OP hysteroscopy services
 NICE also contemplates that hysterocopy services could be offered by GPs


  3. Women should be offered hysterocopy under general anesthesia if she declines OP hysteroscpy
 If a women declines hysteroscopy- offer a pelvic US and explain the limitations of this technique for detecting uterine cavity causes of HMB. ultrasound -women with possible larger fibroids Uterus is palpable abdominally Hx / Examination suggests a pelvic mass Examination inconclusive or difficult , for eg in obese women. Women with suspected adenomyosis Offer transvaginal US if
 ○ significant dysmenorrhoea or
 ○ a bulky , tender uterus that suggests adenomysosis
 If she declines TV US or it is not suitable for her consider 
 ○ Transabdominal US
 ○ MRI and
 
 Explain the limitations of these techniques. Beware that pain associated with HMB may be due to endometriosis rather than adenomysosis. NICE urges not to use saline infusion sonography , MRI or dilatation and curettage for diagnosis of HMB informatio about HMB and treatments – Discuss all options Benefits , risks Suitable treatments if she is trying to conceive If she wants to retain her fertility and / or uterus LUS-IUS-Levonorgestrel- releasing IUS-anticipated changes in bleeding pattern – particularly 1st few cycles and may persist longer than 6 months to wait atleast 6 cycles to see the benefits of the treatment. fertility and treatment -Explain the impact on fertility that any planned surgery or uterine artery embolisation may have and if a potential Rx ( eg hysterectomy or ablation ) involves loss of fertility Explain that uterine artery embolisation or myomectomy may potentially allow them to retain fertility

More Related